haloperidol has been researched along with Action Tremor in 64 studies
Haloperidol: A phenyl-piperidinyl-butyrophenone that is used primarily to treat SCHIZOPHRENIA and other PSYCHOSES. It is also used in schizoaffective disorder, DELUSIONAL DISORDERS, ballism, and TOURETTE SYNDROME (a drug of choice) and occasionally as adjunctive therapy in INTELLECTUAL DISABILITY and the chorea of HUNTINGTON DISEASE. It is a potent antiemetic and is used in the treatment of intractable HICCUPS. (From AMA Drug Evaluations Annual, 1994, p279)
haloperidol : A compound composed of a central piperidine structure with hydroxy and p-chlorophenyl substituents at position 4 and an N-linked p-fluorobutyrophenone moiety.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study suggested that risperidone was superior to haloperidol in improving negative symptoms and better tolerated during the 12 weeks' treatment of schizophrenia." | 9.11 | Adverse effects of risperidone and haloperidol treatment in schizophrenia. ( Chong, MY; Lung, FW; Yen, YC, 2004) |
| "This study used electromyography to describe tremulous jaw movement generated by bilateral electrolytic lesion in the VLS and compare it to tremors induced using subchronic IP treatment with haloperidol, a dopaminergic D2 receptor antagonist." | 7.80 | Induction of mandibular tremor using electrolytic lesion of the ventrolateral striatum or using subchronic haloperidol therapy in male rats: an electromyographic comparison. ( García, LI; Hernández, ME; Herrera-Meza, G; Manzo, J; Miquel, M, 2014) |
| "Tremulous jaw movements in rats can be induced by several conditions associated with parkinsonism and tremorogenesis, including dopamine depletion, dopamine antagonism, and cholinomimetic drugs." | 7.78 | Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation. ( Collins-Praino, LE; Kovner, R; Podurgiel, SJ; Randall, PA; Salamone, JD, 2012) |
| "To characterize the tail-tremor and locomotor hyperactivity induced by repeated nicotine administration, the effects of nicotinic, alpha-adrenergic and dopaminergic blockers were investigated in rats." | 7.69 | Characteristics of tail-tremor induced by nicotine in rats. ( Gomita, Y; Oishi, R; Suemaru, K, 1994) |
| " Oscillations in forelimb force during this performance were spectrally analyzed to describe the tremorogenic effects of haloperidol (0." | 7.68 | A new rodent model for neuroleptic-induced pseudo-parkinsonism: low doses of haloperidol increase forelimb tremor in the rat. ( Fowler, SC; Liao, RM; Skjoldager, P, 1990) |
| "Tremor induced by TRH and oxotremorine was recorded by a capacitance transducer, and its intensity and frequency were evaluated using power arrays." | 7.67 | [Power spectral analysis of tremor induced by TRH and oxotremorine in mice]. ( Fukuda, T; Izumi, K; Koja, T; Nomoto, M; Shimizu, T, 1986) |
| "Acute administration of the anticholinesterase agent carbaryl to rats produced a dose-dependent increase of tremors." | 7.67 | Central cholinergic-dopaminergic interaction in carbaryl-induced tremor. ( Poddar, MK; Ray, SK, 1985) |
| "Tremor was quantified 8 hr later by spectral analysis of whole body movements." | 5.27 | Modulation of p,p'-DDT-induced tremor by catecholaminergic agents. ( Herr, DW; Tilson, HA, 1987) |
| "This study suggested that risperidone was superior to haloperidol in improving negative symptoms and better tolerated during the 12 weeks' treatment of schizophrenia." | 5.11 | Adverse effects of risperidone and haloperidol treatment in schizophrenia. ( Chong, MY; Lung, FW; Yen, YC, 2004) |
| " The extract at both the doses displayed a significant reduction in postural flexion, moderate decrease in tremor, muscular rigidity and postural immobility scores but do not exhibit significant lowering of hypokinesia score in reserpine induced Parkinsonian model." | 4.12 | Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates. ( Kadiri, SK; Karkar, VV; Pal Roy, S; Rao Konijeti, S, 2022) |
| "This study used electromyography to describe tremulous jaw movement generated by bilateral electrolytic lesion in the VLS and compare it to tremors induced using subchronic IP treatment with haloperidol, a dopaminergic D2 receptor antagonist." | 3.80 | Induction of mandibular tremor using electrolytic lesion of the ventrolateral striatum or using subchronic haloperidol therapy in male rats: an electromyographic comparison. ( García, LI; Hernández, ME; Herrera-Meza, G; Manzo, J; Miquel, M, 2014) |
| "Tremulous jaw movements in rats can be induced by several conditions associated with parkinsonism and tremorogenesis, including dopamine depletion, dopamine antagonism, and cholinomimetic drugs." | 3.78 | Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation. ( Collins-Praino, LE; Kovner, R; Podurgiel, SJ; Randall, PA; Salamone, JD, 2012) |
| "In order to better define the role of 5-HT(1A) receptors in the modulation of extrapyramidal motor functions, we investigated the effect of 5-HT(1A) agonists on tacrine-induced tremulous jaw movements (TJM) in rats, a putative model of parkinsonian tremor." | 3.73 | In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties. ( Artaiz, I; Castro, E; Del Olmo, E; Innerárity, A; Labeaga, L; Orjales, A; Pazos, A; Zazpe, A, 2006) |
| "Although most rodent studies related to parkinsonian symptoms have focused on locomotion, tremulous jaw movements also have been used as a rodent model of tremor for investigating the circuitry of the basal ganglia." | 3.72 | Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats. ( Arizzi, MN; Correa, M; Ishiwari, K; Salamone, JD; Wisniecki, A, 2003) |
| " Previous research has reported that haloperidol induces tremulous jaw movements that have many of the characteristics of parkinsonian tremor." | 3.72 | The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism. ( Betz, A; Correa, M; Dobson, DR; O'Neill, MF; O'Neill, MJ; Salamone, JD; Wisniecki, A, 2004) |
| " The standard muscarinic agonists oxotremorine and pilocarpine were both active in these tests but showed little separation between efficacy and cholinergic side effects." | 3.70 | Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity. ( Bymaster, FP; Calligaro, DO; DeLapp, NW; Fink-Jensen, A; Jeppesen, L; Olesen, PH; Rasmussen, T; Rimvall, K; Sauerberg, P; Shannon, HE; Sheardown, MJ; Swedberg, MD; Thomsen, C; Thøgersen, H; Ward, JS, 1998) |
| "To characterize the tail-tremor and locomotor hyperactivity induced by repeated nicotine administration, the effects of nicotinic, alpha-adrenergic and dopaminergic blockers were investigated in rats." | 3.69 | Characteristics of tail-tremor induced by nicotine in rats. ( Gomita, Y; Oishi, R; Suemaru, K, 1994) |
| " Tremorine-induced tremor in mice was inhibited by I-893." | 3.68 | [Pharmacological effects of the novel dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system]. ( Hotta, K; Mizusawa, H; Morita, S; Nagase, T; Omote, M; Sakai, K; Yamane, M, 1991) |
| " Oscillations in forelimb force during this performance were spectrally analyzed to describe the tremorogenic effects of haloperidol (0." | 3.68 | A new rodent model for neuroleptic-induced pseudo-parkinsonism: low doses of haloperidol increase forelimb tremor in the rat. ( Fowler, SC; Liao, RM; Skjoldager, P, 1990) |
| " We present the first case of WES in an infant born to a mother taking haloperidol during her pregnancy." | 3.67 | Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy. ( Barak, Y; Sexson, WR, 1989) |
| "Tremor induced by TRH and oxotremorine was recorded by a capacitance transducer, and its intensity and frequency were evaluated using power arrays." | 3.67 | [Power spectral analysis of tremor induced by TRH and oxotremorine in mice]. ( Fukuda, T; Izumi, K; Koja, T; Nomoto, M; Shimizu, T, 1986) |
| "Acute administration of the anticholinesterase agent carbaryl to rats produced a dose-dependent increase of tremors." | 3.67 | Central cholinergic-dopaminergic interaction in carbaryl-induced tremor. ( Poddar, MK; Ray, SK, 1985) |
| " Over a 24 hour period, the following symptoms could be observed: akathisia, circling, akinesia, choreoathetoid and dystonic movements, oro-facial dyskinesias and postural tremor with or without harmaline." | 3.65 | Haloperidol-induced dyskinesias in the monkey. ( Bédard, P; Delean, J; Lafleur, J; Larochelle, L, 1977) |
| "Either L-dopa, in combination with 1-alpha-methyldopa hydrazine (MK-486), or 1-(2''-pyrimidyl)-4-piperonylpiperazine, an agent that stimulates dopamine receptors, relieves surgically induced tremor in monkeys and concomitantly evokes involuntary movements." | 3.65 | Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent. ( Anagnoste, B; Battista, AF; Fuxe, K; Goldstein, M; Ohmoto, T, 1973) |
| " These findings suggest that acute dystonia is affected by age factor, and that daily dosage or monitoring of drug concentration is unlikely to be a useful marker for the prediction of side-effects during bromperidol treatment." | 1.31 | The characteristics of side-effects of bromperidol in schizophrenic patients. ( Ishida, M; Kaneko, S; Kondo, T; Mihara, K; Otani, K; Tanaka, O; Yasui-Furukori, N, 2002) |
| "While tardive dystonia was distributed relatively evenly in all age groups, almost a third of patients with parkinsonism had it in the eighth decade." | 1.28 | Neurologic approach to drug-induced movement disorders: a study of 125 patients. ( Jankovic, J; Miller, LG, 1990) |
| " When saline was administered instead of TRH for 3 days after long-term administration of TRH, sterotyped behavior was maintained for 2 days but thereafter decreased to some extent." | 1.27 | Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice. ( Furukawa, T; Ushijima, I; Yamada, K, 1984) |
| "Tremor was quantified 8 hr later by spectral analysis of whole body movements." | 1.27 | Modulation of p,p'-DDT-induced tremor by catecholaminergic agents. ( Herr, DW; Tilson, HA, 1987) |
| "Treatment with haloperidol is effective but associated with a high incidence of side effects." | 1.26 | Tics and tremors. ( Golden, GS; Hood, OJ, 1982) |
| "Tremor was seen in 26 of 30 patients being mild in 12, moderate in 11, and severe in three." | 1.26 | Dystonia and tremor in spasmodic torticollis. ( Couch, JR, 1976) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 38 (59.38) | 18.7374 |
| 1990's | 13 (20.31) | 18.2507 |
| 2000's | 8 (12.50) | 29.6817 |
| 2010's | 4 (6.25) | 24.3611 |
| 2020's | 1 (1.56) | 2.80 |
| Authors | Studies |
|---|---|
| Sauerberg, P | 1 |
| Jeppesen, L | 1 |
| Olesen, PH | 1 |
| Rasmussen, T | 1 |
| Swedberg, MD | 1 |
| Sheardown, MJ | 1 |
| Fink-Jensen, A | 1 |
| Thomsen, C | 1 |
| Thøgersen, H | 1 |
| Rimvall, K | 1 |
| Ward, JS | 1 |
| Calligaro, DO | 1 |
| DeLapp, NW | 1 |
| Bymaster, FP | 1 |
| Shannon, HE | 1 |
| Pal Roy, S | 1 |
| Kadiri, SK | 1 |
| Karkar, VV | 1 |
| Rao Konijeti, S | 1 |
| Thorstensen, JR | 1 |
| Tucker, MG | 1 |
| Kavanagh, JJ | 1 |
| Herrera-Meza, G | 1 |
| Manzo, J | 1 |
| Hernández, ME | 1 |
| Miquel, M | 1 |
| García, LI | 1 |
| Collins, LE | 1 |
| Sager, TN | 1 |
| Sams, AG | 1 |
| Pennarola, A | 1 |
| Port, RG | 1 |
| Shahriari, M | 1 |
| Salamone, JD | 4 |
| Collins-Praino, LE | 1 |
| Podurgiel, SJ | 1 |
| Kovner, R | 1 |
| Randall, PA | 1 |
| Thomsen, TW | 1 |
| Brown, DF | 1 |
| Nadel, ES | 1 |
| Ohye, C | 1 |
| Shibazaki, T | 1 |
| Wisniecki, A | 2 |
| Correa, M | 2 |
| Arizzi, MN | 1 |
| Ishiwari, K | 1 |
| Betz, A | 1 |
| Dobson, DR | 1 |
| O'Neill, MF | 1 |
| O'Neill, MJ | 1 |
| Yen, YC | 1 |
| Lung, FW | 1 |
| Chong, MY | 1 |
| Zazpe, A | 1 |
| Artaiz, I | 1 |
| Innerárity, A | 1 |
| Del Olmo, E | 1 |
| Castro, E | 1 |
| Labeaga, L | 1 |
| Pazos, A | 1 |
| Orjales, A | 1 |
| Himwich, WA | 2 |
| Glisson, SN | 1 |
| Ushijima, I | 1 |
| Yamada, K | 1 |
| Furukawa, T | 1 |
| Barbaro, AC | 1 |
| Golden, GS | 1 |
| Hood, OJ | 1 |
| Denijs, EL | 1 |
| Kurkjian, R | 1 |
| Banna, NR | 1 |
| Kurz, M | 1 |
| Hummer, M | 1 |
| Oberbauer, H | 1 |
| Fleischhacker, WW | 1 |
| D'Souza, DC | 1 |
| Bennett, A | 1 |
| Abi-Dargham, A | 1 |
| Krystal, JH | 1 |
| Suemaru, K | 1 |
| Oishi, R | 1 |
| Gomita, Y | 1 |
| Strauss, AJ | 1 |
| Bailey, RK | 1 |
| Dralle, PW | 1 |
| Eschmann, AJ | 1 |
| Wagner, RB | 1 |
| Abduljawad, KA | 2 |
| Langley, RW | 2 |
| Bradshaw, CM | 2 |
| Szabadi, E | 2 |
| Fitzgerald, PB | 1 |
| Kapur, S | 1 |
| Caligiuri, MP | 1 |
| Jones, C | 1 |
| Silvestri, S | 1 |
| Remington, G | 1 |
| Zipursky, RB | 1 |
| Yasui-Furukori, N | 1 |
| Kondo, T | 1 |
| Ishida, M | 1 |
| Tanaka, O | 1 |
| Mihara, K | 1 |
| Kaneko, S | 1 |
| Otani, K | 1 |
| Zarzecki, P | 1 |
| Blake, DJ | 1 |
| Somjen, GG | 1 |
| Bédard, P | 2 |
| Delean, J | 1 |
| Lafleur, J | 1 |
| Larochelle, L | 2 |
| Fink, H | 1 |
| Oelssner, W | 1 |
| Scialli, JV | 1 |
| Thornton, WE | 1 |
| Lenz, G | 1 |
| König, P | 1 |
| Küfferle, B | 1 |
| Beasley, BA | 1 |
| Ford, DH | 1 |
| Couch, JR | 1 |
| Rao, KA | 1 |
| Adlakha, A | 1 |
| Meloy, T | 1 |
| Abraini, JH | 1 |
| Tomei, C | 1 |
| Rostain, JC | 1 |
| Ray, SK | 2 |
| Poddar, MK | 2 |
| Nagase, T | 1 |
| Hotta, K | 1 |
| Morita, S | 1 |
| Sakai, K | 1 |
| Yamane, M | 1 |
| Omote, M | 1 |
| Mizusawa, H | 1 |
| Miller, LG | 1 |
| Jankovic, J | 1 |
| Fowler, SC | 1 |
| Liao, RM | 1 |
| Skjoldager, P | 1 |
| Sexson, WR | 1 |
| Barak, Y | 1 |
| Koja, T | 1 |
| Nomoto, M | 1 |
| Shimizu, T | 1 |
| Izumi, K | 1 |
| Fukuda, T | 1 |
| Colpaert, FC | 1 |
| Herr, DW | 1 |
| Tilson, HA | 1 |
| van Beek, MC | 1 |
| Timmerman, H | 1 |
| Poirier, LJ | 2 |
| Langelier, P | 1 |
| Boucher, R | 1 |
| Parent, A | 1 |
| Roberge, AG | 1 |
| Gumulka, W | 1 |
| Kostowski, W | 1 |
| Czlonkowski, A | 1 |
| Thulin, CA | 1 |
| Blom, S | 1 |
| Marsden, CD | 1 |
| Goldstein, M | 2 |
| Anagnoste, B | 2 |
| Battista, AF | 2 |
| Miyamoto, T | 1 |
| Fuxe, K | 2 |
| Chibanguza, G | 1 |
| Costall, B | 2 |
| Naylor, RJ | 1 |
| Olley, JE | 2 |
| Ohmoto, T | 1 |
| Borgman, RJ | 1 |
| Baylor, MR | 1 |
| McPhillips, JJ | 1 |
| Stitzel, RE | 1 |
| Mori, J | 1 |
| Sato, Y | 1 |
| Oashi, T | 1 |
| Hitomi, M | 1 |
| Cocito, E | 1 |
| Ambrosini, G | 1 |
| Arata, A | 1 |
| Bevilacqua, P | 1 |
| Tortora, E | 1 |
| Ordy, JM | 1 |
| Samorajski, T | 1 |
| Schroeder, DM | 1 |
| Rady-Reimer, P | 1 |
| Nose, T | 1 |
| Kojima, M | 1 |
| Ishida, R | 1 |
| Shintomi, K | 1 |
| Kowa, Y | 1 |
| Rotrosen, J | 1 |
| Wallach, MB | 1 |
| Angrist, B | 1 |
| Gershon, S | 1 |
| Goldstein, S | 1 |
| Leiner, K | 1 |
| Stout, M | 1 |
| Gurovich, IIa | 1 |
| Fleĭs, EP | 1 |
| Morselli, PL | 1 |
| Rizzo, M | 1 |
| Zaccala, M | 1 |
| Garattini, S | 1 |
2 reviews available for haloperidol and Action Tremor
| Article | Year |
|---|---|
Aging and the extrapyramidal system.
Topics: Aged; Aging; Basal Ganglia Diseases; Chlorpromazine; Chorea; Dopamine; Frontal Lobe; Gait; Haloperid | 1976 |
Nervous mechanisms involved in experimentally induced extrapyramidal disturbances.
Topics: Animals; Basal Ganglia Diseases; Benztropine; Brain; Cats; Caudate Nucleus; Cerebellar Nuclei; Chlor | 1974 |
8 trials available for haloperidol and Action Tremor
| Article | Year |
|---|---|
Antagonism of the D
Topics: Biomechanical Phenomena; Cross-Over Studies; Dopamine Antagonists; Double-Blind Method; Electric Sti | 2018 |
Adverse effects of risperidone and haloperidol treatment in schizophrenia.
Topics: Adult; Blood Pressure; Case-Control Studies; Dopamine Antagonists; Dose-Response Relationship, Drug; | 2004 |
Clinical evaluation of bromperidol versus haloperidol in psychotic patients.
Topics: Adult; Aged; Akathisia, Drug-Induced; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; | 1980 |
Extrapyramidal side effects of clozapine and haloperidol.
Topics: Adult; Akathisia, Drug-Induced; Basal Ganglia Diseases; Clozapine; Dyskinesia, Drug-Induced; Female; | 1995 |
Effects of bromocriptine and haloperidol on prepulse inhibition: comparison of the acoustic startle eyeblink response and the N1/P2 auditory-evoked response in man.
Topics: Acoustic Stimulation; Adolescent; Adult; Blinking; Bromocriptine; Dopamine Antagonists; Electromyogr | 1999 |
Instrumentally detected changes in motor functioning in patients with low levels of antipsychotic dopamine D2 blockade.
Topics: Adult; Carbon Radioisotopes; Cerebellum; Corpus Striatum; Dopamine Antagonists; Dopamine D2 Receptor | 2000 |
Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man.
Topics: Acoustic Stimulation; Adolescent; Adult; Affect; Attention; Bromocriptine; Dopamine Agonists; Dopami | 1998 |
Clinical evaluation in 112 psychiatric patients of a butyrophenone neuroleptic, dehydrobenzperidol (R 4749). A controlled study in 45 patients of dehydrobenzperidol versus haloperidol.
Topics: Adult; Asthenia; Benperidol; Catatonia; Clinical Trials as Topic; Depression; Haloperidol; Humans; H | 1970 |
54 other studies available for haloperidol and Action Tremor
| Article | Year |
|---|---|
Muscarinic agonists with antipsychotic-like activity: structure-activity relationships of 1,2,5-thiadiazole analogues with functional dopamine antagonist activity.
Topics: Animals; Antipsychotic Agents; Avoidance Learning; Brain; Dopamine Antagonists; Drug Evaluation, Pre | 1998 |
Antiparkinsonian activity of Tabebuia impetiginosa bark and biochemical analysis of dopamine in rat brain homogenates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adjuvants, Immunologic; Animals; Antioxidants; Antipar | 2022 |
Induction of mandibular tremor using electrolytic lesion of the ventrolateral striatum or using subchronic haloperidol therapy in male rats: an electromyographic comparison.
Topics: Animals; Disease Models, Animal; Dopamine Antagonists; Electromyography; Haloperidol; Jaw; Male; Mot | 2014 |
The novel adenosine A2A antagonist Lu AA47070 reverses the motor and motivational effects produced by dopamine D2 receptor blockade.
Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Choice Behavior; Depression; Dopamine | 2012 |
Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Antagonists; gamma-Aminobutyric Acid; Globus Pallidus; | 2012 |
Pediatric tremors.
Topics: Anti-Dyskinesia Agents; Basal Ganglia Diseases; Child, Preschool; Emergencies; Haloperidol; Humans; | 2002 |
Lesioning the thalamus for dyskinesia.
Topics: Antiparkinson Agents; Antipsychotic Agents; Dyskinesia, Drug-Induced; Dyskinesias; Electrocoagulatio | 2001 |
Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.
Topics: Animals; Behavior, Animal; Bicuculline; Depression, Chemical; Dose-Response Relationship, Drug; Drug | 2003 |
The adenosine A2A antagonist KF17837 reverses the locomotor suppression and tremulous jaw movements induced by haloperidol in rats: possible relevance to parkinsonism.
Topics: Adenosine A2 Receptor Antagonists; Animals; Behavior, Animal; Disease Models, Animal; Dose-Response | 2004 |
In vitro and in vivo characterization of F-97013-GD, a partial 5-HT1A agonist with antipsychotic- and antiparkinsonian-like properties.
Topics: 5-Hydroxytryptophan; Animals; Antiparkinson Agents; Antipsychotic Agents; Apomorphine; Avoidance Lea | 2006 |
Effect of haloperidol on caudate nucleus.
Topics: Animals; Behavior, Animal; Brain Chemistry; Caudate Nucleus; Cerebral Cortex; Dogs; Dopamine; Electr | 1967 |
Acute and long-term effects of thyrotropin releasing hormone on behavior mediated by dopaminergic and cholinergic activities in mice.
Topics: Animals; Atropine; Atropine Derivatives; Behavior, Animal; Dose-Response Relationship, Drug; Haloper | 1984 |
Tremor of the eyelids.
Topics: Adult; Eyelid Diseases; Female; Haloperidol; Humans; Schizophrenia; Tremor | 1984 |
Tics and tremors.
Topics: Adolescent; Child; Child, Preschool; Ethnicity; Female; Haloperidol; Humans; Male; Propranolol; Tic | 1982 |
Dopaminergic mechanisms in thiophene-2-aldoxime tremor.
Topics: Animals; Apomorphine; Catecholamines; Dextroamphetamine; Dopamine; Dopamine Antagonists; Haloperidol | 1982 |
Precipitation of a psychoneuromotor syndrome by fluoxetine in a haloperidol-treated schizophrenic patient.
Topics: Akathisia, Drug-Induced; Drug Therapy, Combination; Fluoxetine; Haloperidol; Humans; Male; Middle Ag | 1994 |
Characteristics of tail-tremor induced by nicotine in rats.
Topics: Animals; Haloperidol; Hexamethonium; Male; Mecamylamine; Motor Activity; Nicotine; Oxotremorine; Rat | 1994 |
Conventional psychotropic-induced tremor extinguished by olanzapine.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Female; Fluphenazine; Haloperidol; Humans; Male; Menta | 1998 |
The characteristics of side-effects of bromperidol in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Dystonia; Female; Haloperidol; Humans; Hypokinesia; Male; Schizophrenia | 2002 |
Neurological disturbances, nigrostriate synapses, and iontophoretic dopamine and apomorphine after haloperidol.
Topics: Animals; Apomorphine; Cats; Caudate Nucleus; Dopamine; Evoked Potentials; Haloperidol; Iontophoresis | 1977 |
Haloperidol-induced dyskinesias in the monkey.
Topics: Animals; Brain; Dyskinesia, Drug-Induced; Haloperidol; Haplorhini; Harmaline; Macaca; Tremor | 1977 |
[Effect of psychotomimetics and haloperidol on head twitching following alcohol withdrawal in mice].
Topics: Animals; Ethanol; Hallucinogens; Haloperidol; Humans; Lysergic Acid Diethylamide; Male; Mescaline; M | 1978 |
Toxic reactions from a haloperidol overdose in two children. Thermal and cardiac manifestations.
Topics: Accidents, Home; Acute Disease; Age Factors; Bradycardia; Child, Preschool; Female; Fever; Haloperid | 1978 |
[Lithium-intoxication masked by neuroleptic drugs in the lithium--saluretic combination (author's transl)].
Topics: Bipolar Disorder; Delusions; Drug Interactions; Haloperidol; Humans; Lithium; Male; Middle Aged; Tre | 1977 |
Dystonia and tremor in spasmodic torticollis.
Topics: Adult; Age Factors; Aged; Dystonia Musculorum Deformans; Facial Nerve; Female; Haloperidol; Humans; | 1976 |
Tremor, confusion, and autonomic dysfunction in Down syndrome.
Topics: Adult; Autonomic Nervous System Diseases; Confusion; Diagnosis, Differential; Down Syndrome; Haloper | 1992 |
Role of dopamine receptors in the occurrence of the behavioral motor disturbances in rats exposed to high pressure.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Atmospheric Pressu | 1991 |
Interaction of central serotonin and dopamine in the regulation of carbaryl-induced tremor.
Topics: 5-Hydroxytryptophan; Acetylcholinesterase; Animals; Atropine; Behavior, Animal; Brain Chemistry; Bro | 1990 |
[Pharmacological effects of the novel dopamine uptake inhibitor 1-[2-[bis(4-fluorophenyl)-methoxy]ethyl]-4-(3-phenylpropyl) piperazine dihydrochloride (I-893) on the central nervous system].
Topics: Animals; Barbiturates; Body Temperature; Catalepsy; Dogs; Dopamine; Dose-Response Relationship, Drug | 1991 |
Neurologic approach to drug-induced movement disorders: a study of 125 patients.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Amitriptyline; Antipsychotic Agents; Chorea | 1990 |
A new rodent model for neuroleptic-induced pseudo-parkinsonism: low doses of haloperidol increase forelimb tremor in the rat.
Topics: Animals; Atropine; Disease Models, Animal; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induce | 1990 |
Withdrawal emergent syndrome in an infant associated with maternal haloperidol therapy.
Topics: Adult; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Infant; Infant, Newborn; Male; Neonata | 1989 |
[Power spectral analysis of tremor induced by TRH and oxotremorine in mice].
Topics: Animals; Atropine; Haloperidol; Male; Mice; Oxotremorine; Propranolol; Reaction Time; Thyrotropin-Re | 1986 |
Pharmacological characteristics of tremor, rigidity and hypokinesia induced by reserpine in rat.
Topics: Animals; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Female; Haloperidol; Levodop | 1987 |
Modulation of p,p'-DDT-induced tremor by catecholaminergic agents.
Topics: Animals; Apomorphine; Clonidine; DDT; Dopamine; Haloperidol; Male; Norepinephrine; Phenoxybenzamine; | 1987 |
Central cholinergic-dopaminergic interaction in carbaryl-induced tremor.
Topics: Animals; Atropine; Carbaryl; Carbidopa; Dose-Response Relationship, Drug; Drug Synergism; Haloperido | 1985 |
Some benzhydryl derivatives as central dopamine receptor stimulating agents.
Topics: Animals; Apomorphine; Behavior, Animal; Benzyl Compounds; Brain; Chlorpromazine; Dihydroxyphenylalan | 1974 |
Dopaminergic and cholinergic mechanisms in relation to postural tremor in the monkey and circling movements in the cat.
Topics: Acetylcholine; Amphetamine; Animals; Cats; Corpus Striatum; Disease Models, Animal; Dopamine; Fronta | 1974 |
Role of 5-HT in the action of some drugs affecting extrapyramidal system.
Topics: Amphetamine; Animals; Brain; Catalepsy; Chlorpromazine; Electrodes; Extrapyramidal Tracts; Female; F | 1973 |
Rigidity and tremor induced in feline muscles deprived of their fusiomtor control.
Topics: Achilles Tendon; Animals; Animals, Newborn; Cats; Disease Models, Animal; Electromyography; Haloperi | 1974 |
Drug treatment of diseases characterized by abnormal movements.
Topics: Chorea; Diazepam; Ethanol; Haloperidol; Humans; Huntington Disease; Levodopa; Movement Disorders; My | 1973 |
Mechanisms involved in the control of extrapyramidal dysfunctions and in striatal dopamine synthesis.
Topics: Animals; Antiparkinson Agents; Apomorphine; Basal Ganglia Diseases; Bucladesine; Carbidopa; Carbon R | 1974 |
[The emetic action of theophylline in the dog].
Topics: Animals; Chlorpromazine; Dogs; Dose-Response Relationship, Drug; Emetics; Haloperidol; Myotonia; Nau | 1974 |
Catalepsy and circling behaviour after intracerebral injections of neuroleptic, cholinergic and anticholinergic agents into the caudate-putamen, globus pallidus and substantia nigra of rat brain.
Topics: Animals; Arecoline; Atropine; Behavior, Animal; Catalepsy; Caudate Nucleus; Corpus Striatum; Diffusi | 1972 |
Tremor and involuntary movements in monkeys: effect of L-dopa and of a dopamine receptor stimulating agent.
Topics: 5-Hydroxytryptophan; Animals; Benzyl Compounds; Dihydroxyphenylalanine; Dioxoles; Drug Interactions; | 1973 |
Alpha-methyldopamine derivatives. Synthesis and pharmacology.
Topics: Animals; Apomorphine; Blepharoptosis; Body Temperature; Depression, Chemical; Dihydroxyphenylalanine | 1974 |
[Pharmacological study of amantadine, a new antiparkinson drug].
Topics: Amantadine; Amines; Animals; Antiparkinson Agents; Avoidance Learning; Brain; Catatonia; Dopamine; D | 1974 |
Haloperidol and electric shock interaction effects on tremors and on catecholamine concentrations in the caudate nucleus of the squirrel monkey.
Topics: Analysis of Variance; Animals; Catecholamines; Caudate Nucleus; Dopamine; Electroshock; Extrapyramid | 1969 |
[Pharmacological properties of 6,6,9-trimethyl-9-azabicyclo (3,3,1)non-3 beta-yl-alpha, alpha-di(2-thienyl) glycolate hydrochloride monohydrate (PG-501), a new anti-parkinsonian agent].
Topics: Acetylcholine; Analgesics; Anesthetics, Local; Animals; Anticonvulsants; Barbiturates; Behavior, Ani | 1971 |
Antagonism of apomorphine-induced sterotypy and emesis in dogs by thioridazine, haloperidol, and pimozide.
Topics: Animals; Apomorphine; Behavior, Animal; Blood-Brain Barrier; Chemoreceptor Cells; Corpus Striatum; D | 1972 |
Cholinergic and neuroleptic induced catalepsy: modification by lesions in the globus pallidus and substantia nigra.
Topics: Animals; Behavior, Animal; Catalepsy; Drug Synergism; Globus Pallidus; Haloperidol; Humans; Nicotini | 1971 |
Psychoactive agents in dogs with bilateral lesions in subcortical structures.
Topics: 5-Hydroxytryptophan; Animals; Caudate Nucleus; Chlorpromazine; Dogs; Dopamine; Haloperidol; Hippocam | 1971 |
[A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
Topics: Aged; Bipolar Disorder; Chlorpromazine; Chronic Disease; Extrapyramidal Tracts; Female; Haloperidol; | 1969 |
Haloperidol-desipramine interaction in mice, rats and man.
Topics: Animals; Basal Ganglia Diseases; Benperidol; Butyrophenones; Chronic Disease; Desipramine; Drug Anta | 1970 |